GE HealthCare Technologies (NASDAQ:GEHC) Receives Hold (C+) Rating from Weiss Ratings

Weiss Ratings restated their hold (c+) rating on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research note published on Tuesday,Weiss Ratings reports.

A number of other equities analysts also recently weighed in on GEHC. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their target price for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Barclays assumed coverage on shares of GE HealthCare Technologies in a research note on Monday. They set an “equal weight” rating and a $86.00 target price for the company. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research note on Thursday, September 18th. Finally, BTIG Research increased their target price on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $85.20.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $72.34 on Tuesday. GE HealthCare Technologies has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a 50 day simple moving average of $74.36 and a two-hundred day simple moving average of $72.16. The company has a market capitalization of $33.03 billion, a price-to-earnings ratio of 14.82, a P/E/G ratio of 2.74 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter last year, the firm earned $1.00 earnings per share. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after acquiring an additional 703,903 shares during the last quarter. Dodge & Cox boosted its stake in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. State Street Corp boosted its stake in shares of GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after acquiring an additional 372,755 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after acquiring an additional 231,302 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of GE HealthCare Technologies during the 2nd quarter worth $468,120,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.